Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.169EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.43EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.442EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.51EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.106EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
D.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.593EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.290EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.341EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.161EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.69 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.407EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.423EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.281EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AE.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.230EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.535EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-20208.4South Korea
A.24EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.564.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
S.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.215EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.36.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.218EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBNEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.356EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.462EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.147EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.6 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.5 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.4 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.420EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.428EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.355EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.34.1.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.71 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used